Payment Commission Data Act of 2019
- Last Action
- 2/15/2019
Actions
- 2019-02-15Referred to the Subcommittee on Health.
- 2019-02-14Referred to the Subcommittee on Health.
- 2019-02-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-02-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-02-14Introduced in House
- 2019-02-14Introduced in House
CRS Summary
As of 2019-02-14 (00)
Payment Commission Data Act of 2019
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Subjects
- Advisory bodies
- Health care costs and insurance
- Health information and medical records
- Health programs administration and funding
- Medicaid
- Medicare
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.